GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **726 - 750** of **4050** in total

« First

‹ Prev

…

26

27

28

29

30

31

32

33

34

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgG	Patient 3	4	mild	G58969RU	45
IgG	Patient 1	10	moderate	G65889KE	46
IgG	Patient 1	22	moderate	G30839DN	46
IgG	Patient 1	22	moderate	G68703KI	46
IgM	Patient 1	10	moderate	G08520NM	46
IgM	Patient 1	10	moderate	G29011JC	46
IgM	Patient 1	10	moderate	G76355TG	46
IgM	Patient 1	10	moderate	G78074HX	46
IgM	Patient 1	10	moderate	G89993FE	46
IgG	Patient 2	15	mild	G25407RZ	46
IgG	Patient 2	15	mild	G66937TJ	46
IgG	Patient 2	24	mild	G09482NW	46
IgG	Patient 2	24	mild	G25407RZ	46
IgG	Patient 2	24	mild	G32699RJ	46
IgG	Patient 2	24	mild	G63074CQ	46
IgG	Patient 2	24	mild	G86566MF	46
IgM	Patient 2	24	mild	G00053MO	46
IgM	Patient 2	24	mild	G24432YB	46
IgM	Patient 1	6	moderate	G21675ZL	46
IgM	Patient 1	6	moderate	G51872EK	46
IgM	Patient 1	6	moderate	G73271MD	46
IgG	Patient 2	3	mild	G14844CX	46
IgG	Patient 2	3	mild	G29857RC	46
IgM	Patient 2	3	mild	G00052MO	46
IgG	Patient 3	-180	mild	G02557XE	46